Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cappelli

Showing results (181-190 of 196) with videos related to

Pageof 20
Sort By:
Journal of the American Heart Association|November 12, 2025
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin CardiomyopathyAlberto Aimo, Martina Nesti, Giuseppe Vergaro, et al.
JAMA Cardiology|November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label ExtensionKevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 20, 2025
Change in prevalence of ATTR variants in Italy - Results from a National SurveyCarlo Fumagalli, Simone Longhi, Alberto Aimo, et al.
European Heart Journal|March 22, 2023
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosisMuhammad Umaid Rauf, Philip N Hawkins, Francesco Cappelli, et al.
European Journal of Heart Failure|June 18, 2024
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosisSteven A Muller, Belén Peiró-Aventin, Giulia Biagioni, et al.
European Heart Journal|April 9, 2026
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impactFrancesco Cappelli, Carlo Fumagalli, Marco Luigetti, et al.
Revista Espanola De Cardiologia (English Ed.)|June 23, 2026
Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplantAlessia Argirò, Federica Colio, Manuel Garofalo, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
Pageof 20

Showing results (181-190 of 196) with videos related to

Sort By:
Pageof 20
Journal of the American Heart Association|November 12, 2025
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin CardiomyopathyAlberto Aimo, Martina Nesti, Giuseppe Vergaro, et al.
JAMA Cardiology|November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label ExtensionKevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 20, 2025
Change in prevalence of ATTR variants in Italy - Results from a National SurveyCarlo Fumagalli, Simone Longhi, Alberto Aimo, et al.
European Heart Journal|March 22, 2023
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosisMuhammad Umaid Rauf, Philip N Hawkins, Francesco Cappelli, et al.
European Journal of Heart Failure|June 18, 2024
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosisSteven A Muller, Belén Peiró-Aventin, Giulia Biagioni, et al.
European Heart Journal|April 9, 2026
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impactFrancesco Cappelli, Carlo Fumagalli, Marco Luigetti, et al.
Revista Espanola De Cardiologia (English Ed.)|June 23, 2026
Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplantAlessia Argirò, Federica Colio, Manuel Garofalo, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
Pageof 20